Poland· PL-100431553
Atgam
A antilymphocyte immunoglobulin (horse) product containing immunoglobulina końska przeciw ludzkim limfocytom t (eatg), registered in Poland by Pfizer Europe MA EEIG. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Antilymphocyte immunoglobulin (horse) is registered in 9 of 19 countries.
Countries holding a registration under ATC L04AA03 (antilymphocyte immunoglobulin (horse)), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Antilymphocyte immunoglobulin (horse) · ATC L04AA03
9 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Immunoglobulina końska przeciw ludzkim limfocytom T (eATG)
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Poland (PL)
- ATC code
- L04AA03
- ATC class
- Antilymphocyte immunoglobulin (horse)
- Defined daily dose
- 1.05 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin09088885508485
- gtin05415062384244
- gtin09088884452482
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L04AA03
Antilymphocyte immunoglobulin (horse), as other registers publish it.
- FinlandAtgamPfizer Oy
- SwitzerlandAtgam
- NorwayAtgamPFIZER AS
- DenmarkAtgamPfizer ApS
- CanadaATGAMPFIZER CANADA ULC
- BelgiumAtgam 50 mg/mlPfizer
- NetherlandsAtgam 50 mg/ml concentraat voor oplossing voor infusiePfizer B.V.
- IrelandAtgam 50 mg/ml concentrate for solution for infusionPfizer Healthcare Ireland Unlimited Company
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/51381638-5a1b-44dd-97d7-4d14678f9401 GET /v1/drugs/51381638-5a1b-44dd-97d7-4d14678f9401?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "50 mg/ml",
"packaging": "05415062384244 ¦ Lz ¦ 145772\n5 amp. 5 ml\n¦ UR/Z/4c/206/26 - 09088884452482",
"substance": "Immunoglobulina końska przeciw ludzkim limfocytom T (eATG) 50 mg/ml",
"common_name": "Immunoglobulina końska przeciw ludzkim limfocytom T (eATG)",
"pl_product_id": "100431553",
"pozwolenie_nr": "27126",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about antilymphocyte immunoglobulin (horse).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.